Research & Development



第五十二章 榜樣的力量   “用不完我們可以拿出去跟匈奴交換牛羊啊,跟西域交換金銀,銅,乃至于香料,地毯,干果。必要的時候還能用絲帛雇佣西域人幫我們作戰圍剿匈奴。我想不通啊,前段時間阿嬌說雞蛋太多了,現在你又說絲帛太多了,那里多了?你沒見農婦在地里干活的時候連衣衫都舍不得穿?”宝马彩票app下载送38   劉二笑道︰“不算糊弄,還給了一萬個錢,不錯了……”038彩票安卓大厅   她嘴里說的那些名詞雲瑯很陌生,只有一個稷下學宮在史書上還有點名氣,剩下的簡直聞所未聞。   年輕的官員咳嗽一聲,朗聲道︰“二月初六,上諭,上林苑歸屬少府事。”038彩票手机版   裹著肉汁的白米飯一連吞了兩勺之後,甦稚才含糊不清的對雲瑯撒嬌。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo